BioSpace News Archive

Biotech Bay

HumanFirst Opens Up Atlas Platform to Scale Use of Decentralized Clinical Trials

Offering complimentary access to searchable data on thousands of connected sensors to measure digital biomarkers in clinical trials, HumanFirst gives biopharma a new solution to navigate the rapidly evolving landscape of connected health products.

January 18, 2022
·
2 min read
Biotech Bay

Clinical Data Presented at 2022 North American Neuromodulation Society (NANS) Annual Meeting Reinforce Significant and Durable Benefits of Nevro’s 10 kHz Therapy

SENZA-PDN Randomized Controlled Trial Results Demonstrate Significant and Sustained Outcomes with 10 kHz Therapy at 18-Months Follow-Up.

January 18, 2022
·
8 min read
Biotech Beach

BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests

BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19.

January 18, 2022
·
2 min read
Business

CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer

CorVista Health, Inc. announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer.

January 18, 2022
·
3 min read
Genetown

bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD)

bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD).

January 18, 2022
·
11 min read
Drug Development

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

Resverlogix Corp. (“Resverlogix”) (TSX:RVX) is pleased to announce today that enrollment and dosing of patients has commenced in a Phase 2b study at a site at the University of Alberta Hospital in Edmonton.

January 18, 2022
·
6 min read
Business

Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update

Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update.

January 18, 2022
·
6 min read
Drug Development

Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy

Profound Medical Corp. today announced that the first patients have been treated in the Level 1 ‘ CAPTAIN ’ trial.

January 18, 2022
·
5 min read
Business

Foldax Appoints Scott Huennekens to Board of Directors

Foldax® , Inc. today announced the appointment of medical device veteran Scott Huennekens as an independent member of the company’s board of directors.

January 18, 2022
·
2 min read
BioMidwest

Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology

Nutriband Inc. announced an expanded product development pipeline for its proprietary AVERSA™ abuse deterrent transdermal technology.

January 18, 2022
·
4 min read